The technology has been awarded ~$5 million in grant and equity funding (PI of award).

• Texas Emerging Technology Fund
• NIH five year collaborative award with leading academic institutions (Dr. Hook)
• U.T. M. D. Anderson Cancer Center MRP Award (Dr. Dickey)
• AlphaDev partnership
• “Living Legends” fund (Dr. Dickey)
• Culpeper award (Dr. Evans)
• NCI Leukemia SPORE grant (Dr. Evans)
• Inaugural Texas Ignition Fund award
• Lehman Brothers Foundation award (Dr. Dickey)
• U.T. M. D. Anderson Cancer Center – Technology Review Committee
• Phase I SBIR (Dr. Scott)